- Home
- STCN vs PTHL Comparison
STCN vs PTHL Comparison
Compare STCN & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STCN
- PTHL
- Stock Information
- Founded
- STCN 1986
- PTHL 1998
- Country
- STCN United States
- PTHL China
- Employees
- STCN N/A
- PTHL N/A
- Industry
- STCN Advertising
- PTHL
- Sector
- STCN Consumer Discretionary
- PTHL
- Exchange
- STCN Nasdaq
- PTHL Nasdaq
- Market Cap
- STCN 63.4M
- PTHL 65.0M
- IPO Year
- STCN 1994
- PTHL 2024
- Fundamental
- Price
- STCN $9.80
- PTHL $4.25
- Analyst Decision
- STCN
- PTHL
- Analyst Count
- STCN 0
- PTHL 0
- Target Price
- STCN N/A
- PTHL N/A
- AVG Volume (30 Days)
- STCN 30.8K
- PTHL 148.5K
- Earning Date
- STCN 12-12-2024
- PTHL 11-26-2024
- Dividend Yield
- STCN N/A
- PTHL N/A
- EPS Growth
- STCN 203.29
- PTHL N/A
- EPS
- STCN 3.11
- PTHL N/A
- Revenue
- STCN $174,109,000.00
- PTHL $572,291.00
- Revenue This Year
- STCN N/A
- PTHL N/A
- Revenue Next Year
- STCN N/A
- PTHL N/A
- P/E Ratio
- STCN $3.27
- PTHL N/A
- Revenue Growth
- STCN N/A
- PTHL 2.32
- 52 Week Low
- STCN $7.36
- PTHL $3.32
- 52 Week High
- STCN $13.00
- PTHL $6.45
- Technical
- Relative Strength Index (RSI)
- STCN 40.83
- PTHL N/A
- Support Level
- STCN $9.66
- PTHL N/A
- Resistance Level
- STCN $10.32
- PTHL N/A
- Average True Range (ATR)
- STCN 0.61
- PTHL 0.00
- MACD
- STCN -0.02
- PTHL 0.00
- Stochastic Oscillator
- STCN 8.81
- PTHL 0.00
About STCN Steel Connect Inc.
Steel Connect Inc is a diversified holding company. The company's operating segment include Direct Marketing and Supply Chain. It generates maximum revenue from the Direct Marketing segment. Geographically, it derives a majority of revenue from the United States and also has a presence in China; Netherlands, and others. The company serves clients in various industries including consumer electronics, communications, computing, software, storage, and retail industries.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.